Both in Pharmaceuticals
Savara vs Syndax Pharmaceuticals
Over the past year SVRA returned +12.8% and SNDX returned −31.9%; their daily moves had a correlation of 0.38.
SVRA +12.8% SNDX −31.9%Growth of $1, one year, split-adjusted
| Metric | SVRA | SNDX |
|---|---|---|
| Price | $4.66 | $10.45 |
| Market cap | $957.4M | $933.2M |
| Today | −1.89% | −26.87% |
| 1 month | +0.2% | −39.8% |
| 6 months | −11.6% | −49.4% |
| Year to date | −22.7% | −50.3% |
| 1 year | +9.1% | −24.1% |
| Revenue growth (YoY) | — | +81.6% |
| Gross margin | — | 83.2% |
| Net margin | — | −59.3% |
| P/E (TTM) | — | — |
| Price / sales | — | 3.2× |
| Net cash | $142.9M | $182.3M |
| Dividend yield | — | — |
| Volatility (60d) | 48.3% | 84.0% |
| Short % of float | 20.1% | 21.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).